Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114 [Peer Reviewed Journal]2015 INIST-CNRS ;2013 by American Society of Clinical Oncology 2013 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.47.4189 ;PMID: 24101053
Full text available